Search research articles
Contact Us
Filters
Showing results (221-230 of 390) with videos related to
Page
of 39
Sort By:
Journal of the Neurological Sciences
|
August 15, 2018
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy
Ilya Kister, Tim Spelman, Francesco Patti, et al.
Plos One
|
April 7, 2010
Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients
Cathy J Jensen, Jim Stankovich, Anneke Van der Walt, et al.
Neuroimage. Clinical
|
September 1, 2021
Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study
Michael Barnett, Niels Bergsland, Bianca Weinstock-Guttman, et al.
Annals of Clinical and Translational Neurology
|
February 26, 2025
Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis
Yi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
Glia
|
February 3, 2015
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor
Melissa M Gresle, Helmut Butzkueven, Victoria M Perreau, et al.
JAMA Neurology
|
September 14, 2020
Association of Pregnancy With the Onset of Clinically Isolated Syndrome
Ai-Lan Nguyen, Karolina Vodehnalova, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 20, 2025
Disease course after pregnancy in women with progressive multiple sclerosis symptoms
Jessica Shipley, Heidi N Beadnall, Paul G Sanfilippo, et al.
JAMA Neurology
|
September 29, 2025
Menopause Impact on Multiple Sclerosis Disability Progression
Francesca Bridge, Paul G Sanfilippo, Chao Zhu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 19, 2024
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry
Alessio Signori, Marta Ponzano, Tomas Kalincik, et al.
Neurology. Clinical Practice
|
January 29, 2021
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS
Andrew Chan, John Rose, Enrique Alvarez, et al.
Page
of 39
Search research articles
Search
Showing results (221-230 of 390) with videos related to
Sort By:
Page
of 39
Journal of the Neurological Sciences
|
August 15, 2018
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy
Ilya Kister, Tim Spelman, Francesco Patti, et al.
Plos One
|
April 7, 2010
Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients
Cathy J Jensen, Jim Stankovich, Anneke Van der Walt, et al.
Neuroimage. Clinical
|
September 1, 2021
Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study
Michael Barnett, Niels Bergsland, Bianca Weinstock-Guttman, et al.
Annals of Clinical and Translational Neurology
|
February 26, 2025
Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis
Yi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
Glia
|
February 3, 2015
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor
Melissa M Gresle, Helmut Butzkueven, Victoria M Perreau, et al.
JAMA Neurology
|
September 14, 2020
Association of Pregnancy With the Onset of Clinically Isolated Syndrome
Ai-Lan Nguyen, Karolina Vodehnalova, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 20, 2025
Disease course after pregnancy in women with progressive multiple sclerosis symptoms
Jessica Shipley, Heidi N Beadnall, Paul G Sanfilippo, et al.
JAMA Neurology
|
September 29, 2025
Menopause Impact on Multiple Sclerosis Disability Progression
Francesca Bridge, Paul G Sanfilippo, Chao Zhu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 19, 2024
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry
Alessio Signori, Marta Ponzano, Tomas Kalincik, et al.
Neurology. Clinical Practice
|
January 29, 2021
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS
Andrew Chan, John Rose, Enrique Alvarez, et al.
Page
of 39